Mary Hannan1, Alana Steffen2, Lauretta Quinn3, Eileen G Collins3, Shane A Phillips4, Ulf G Bronas3. 1. Department of Biobehavioral Health Science, College of Nursing, University of Illinois at Chicago, Chicago, IL, USA. mhanna22@uic.edu. 2. Department of Health Systems Science, College of Nursing, University of Illinois at Chicago, Chicago, IL, USA. 3. Department of Biobehavioral Health Science, College of Nursing, University of Illinois at Chicago, Chicago, IL, USA. 4. Department of Physical Therapy, College of Allied Health Science, University of Illinois at Chicago, Chicago, IL, USA.
Abstract
INTRODUCTION: Chronic kidney disease (CKD) is a common chronic condition in older adults that is associated with cognitive decline. However, the exact prevalence of cognitive impairment in older adults with CKD is unclear likely due to the variety of methods utilized to assess cognitive function. The purpose of this integrative review is to determine how cognitive function is most frequently assessed in older adult patients with CKD. METHODS: Five electronic databases were searched to explore relevant literature related to cognitive function assessment in older adult patients with CKD. Inclusion and exclusion criteria were created to focus the search to the assessment of cognitive function with standardized cognitive tests in older adults with CKD, not on renal replacement therapy. RESULTS: Through the search methods, 36 articles were found that fulfilled the purpose of the review. There were 36 different types of cognitive tests utilized in the included articles, with each study utilizing between one and 12 tests. The most commonly utilized cognitive test was the Mini Mental State Exam (MMSE), followed by tests of digit symbol substitution and verbal fluency. The most commonly assessed aspect of cognitive function was global cognition. DISCUSSION: The assessment of cognitive function in older adults with CKD with standardized tests is completed in various ways. Unfortunately, the common methods of assessment of cognitive function may not be fully examining the domains of impairment commonly found in older adults with CKD. Further research is needed to identify the ideal cognitive test to best assess older adults with CKD for cognitive impairment.
INTRODUCTION:Chronic kidney disease (CKD) is a common chronic condition in older adults that is associated with cognitive decline. However, the exact prevalence of cognitive impairment in older adults with CKD is unclear likely due to the variety of methods utilized to assess cognitive function. The purpose of this integrative review is to determine how cognitive function is most frequently assessed in older adult patients with CKD. METHODS: Five electronic databases were searched to explore relevant literature related to cognitive function assessment in older adult patients with CKD. Inclusion and exclusion criteria were created to focus the search to the assessment of cognitive function with standardized cognitive tests in older adults with CKD, not on renal replacement therapy. RESULTS: Through the search methods, 36 articles were found that fulfilled the purpose of the review. There were 36 different types of cognitive tests utilized in the included articles, with each study utilizing between one and 12 tests. The most commonly utilized cognitive test was the Mini Mental State Exam (MMSE), followed by tests of digit symbol substitution and verbal fluency. The most commonly assessed aspect of cognitive function was global cognition. DISCUSSION: The assessment of cognitive function in older adults with CKD with standardized tests is completed in various ways. Unfortunately, the common methods of assessment of cognitive function may not be fully examining the domains of impairment commonly found in older adults with CKD. Further research is needed to identify the ideal cognitive test to best assess older adults with CKD for cognitive impairment.
Authors: Emma O'Lone; Michael Connors; Philip Masson; Sunny Wu; Patrick J Kelly; David Gillespie; Daniel Parker; William Whiteley; Giovanni F M Strippoli; Suetonia C Palmer; Jonathan C Craig; Angela C Webster Journal: Am J Kidney Dis Date: 2016-02-23 Impact factor: 8.860
Authors: Brendan Darsie; Michael G Shlipak; Mark J Sarnak; Ronit Katz; Annette L Fitzpatrick; Michelle C Odden Journal: Am J Epidemiol Date: 2014-05-20 Impact factor: 4.897
Authors: Manjula Kurella; Kristine Yaffe; Michael G Shlipak; Nanette K Wenger; Glenn M Chertow Journal: Am J Kidney Dis Date: 2005-01 Impact factor: 8.860
Authors: Stephen L Seliger; David S Siscovick; Catherine O Stehman-Breen; Daniel L Gillen; Annette Fitzpatrick; Anthony Bleyer; Lew H Kuller Journal: J Am Soc Nephrol Date: 2004-07 Impact factor: 10.121
Authors: Mary Hannan; Eileen G Collins; Shane A Phillips; Lauretta Quinn; Alana Steffen; Ulf G Bronas Journal: Aging Clin Exp Res Date: 2020-09-09 Impact factor: 4.481